• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Hematologic parameters in patients with COVID-19 infection: a reply.

作者信息

Fan Bingwen Eugene

机构信息

Department of Haematology, Tan Tock Seng Hospital, Singapore.

Department of Laboratory Medicine, Khoo Teck Puat Hospital, Singapore.

出版信息

Am J Hematol. 2020 Aug;95(8):E215. doi: 10.1002/ajh.25847. Epub 2020 May 29.

DOI:10.1002/ajh.25847
PMID:32339335
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7267477/
Abstract
摘要

相似文献

1
Hematologic parameters in patients with COVID-19 infection: a reply.新型冠状病毒肺炎感染患者的血液学参数：答复
Am J Hematol. 2020 Aug;95(8):E215. doi: 10.1002/ajh.25847. Epub 2020 May 29.
2
Treatments for COVID-19: emerging drugs against the coronavirus - reply.新型冠状病毒肺炎的治疗方法：对抗冠状病毒的新型药物——回复
Acta Biomed. 2020 Jun 30;91(3):ahead of print. doi: 10.23750/abm.v91i3.10108.
3
COVID-19 Infection: Perioperative Implications: Reply.2019冠状病毒病感染：围手术期影响：回复
Anesthesiology. 2020 Sep;133(3):678-679. doi: 10.1097/ALN.0000000000003424.
4
Reply Letter - COVID-19 (Novel Coronavirus 2019) - Recent trends.回复信 - 2019冠状病毒病（新型冠状病毒2019） - 近期趋势
Eur Rev Med Pharmacol Sci. 2020 Jun;24(12):6482-6483. doi: 10.26355/eurrev_202006_21629.
5
Reply to "Coronavirus Disease 19 (COVID-19): Implications for Clinical Dental Care".对《2019冠状病毒病（COVID-19）：对临床牙科护理的影响》的回复
J Endod. 2020 Sep;46(9):1342. doi: 10.1016/j.joen.2020.08.005. Epub 2020 Aug 15.
6
In Reply: Correctly Interpreting SARS-CoV-2 Serologic Assays.回复：正确解读严重急性呼吸综合征冠状病毒2血清学检测
Clin Chem. 2020 Sep 1;66(9):1245-1247. doi: 10.1093/clinchem/hvaa166.
7
Perioperative Care for Patients with COVID-19: Reply.
Anesthesiology. 2020 Sep;133(3):680-681. doi: 10.1097/ALN.0000000000003449.
8
Risk of COVID-19 in Patients With Cancer-Reply.癌症患者感染新型冠状病毒肺炎的风险——回复
JAMA Oncol. 2020 Sep 1;6(9):1472-1473. doi: 10.1001/jamaoncol.2020.2589.
9
COVID-19 Transmission Conclusions Justified by the Analysis Results?-Reply.
JAMA Intern Med. 2020 Sep 1;180(9):1262-1264. doi: 10.1001/jamainternmed.2020.4100.
10
In Reply to the Letter to the Editor Regarding "The Return Back to Typical Practice from the 'Battle Plan' of the COVID-19 Pandemic: A Comparative Study".回复致编辑的关于《从新冠疫情“作战计划”回归常规实践：一项比较研究》的信。
World Neurosurg. 2020 Nov;143:595. doi: 10.1016/j.wneu.2020.08.131.

引用本文的文献

1
COVID-19 and acute limb ischemia: latest hypotheses of pathophysiology and molecular mechanisms.2019冠状病毒病与急性肢体缺血：病理生理学和分子机制的最新假说
J Zhejiang Univ Sci B. 2025 Feb 19;26(4):333-352. doi: 10.1631/jzus.B2300512.
2
Early Identification of Severe COVID-19 Cases and the Need for ICU Care Based on Clinical and Laboratory Risk Factors.基于临床和实验室风险因素的重症COVID-19病例的早期识别及重症监护需求
Cureus. 2025 Mar 15;17(3):e80611. doi: 10.7759/cureus.80611. eCollection 2025 Mar.
3
Prediction of hospitalization time probability for COVID-19 patients with statistical and machine learning methods using blood parameters.使用血液参数，通过统计和机器学习方法预测新冠病毒肺炎患者的住院时间概率
Ann Med Surg (Lond). 2024 Sep 4;86(12):7125-7134. doi: 10.1097/MS9.0000000000002477. eCollection 2024 Dec.
4
Could Anemia Impact the Severity of Infections? COVID-19 as an Example.贫血会影响感染的严重程度吗？以新冠病毒为例。
F1000Res. 2024 Nov 5;13:295. doi: 10.12688/f1000research.144790.2. eCollection 2024.
5
Assessment of the hematological profiles among COVID-19 patients during the first and second waves in Ethiopia: A multicenter retrospective cohort study.埃塞俄比亚第一波和第二波新冠疫情期间新冠患者血液学指标评估：一项多中心回顾性队列研究
SAGE Open Med. 2024 May 20;12:20503121241253522. doi: 10.1177/20503121241253522. eCollection 2024.
6
Hematocytological Clues of Peripheral Blood in Different Clinical Presentations of COVID-19.新型冠状病毒肺炎不同临床表现中外周血的血细胞学线索
Iran J Pathol. 2023 Summer;18(3):270-278. doi: 10.30699/IJP.2023.561331.2963. Epub 2023 Jul 16.
7
Outcomes of COVID-19 in immunocompromised patients: a single center experience.免疫功能低下患者的新型冠状病毒肺炎结局：单中心经验
Virusdisease. 2023 Sep;34(3):373-382. doi: 10.1007/s13337-023-00832-z. Epub 2023 Aug 10.
8
Pathological Effects of SARS-CoV-2 Associated with Hematological Abnormalities.与血液学异常相关的新型冠状病毒2型（SARS-CoV-2）的病理效应
Curr Issues Mol Biol. 2023 Aug 28;45(9):7161-7182. doi: 10.3390/cimb45090453.
9
The Evaluation of Hematological Parameters and Their Correlation with Disease Prognosis in COVID-19 Disease in Iran.伊朗COVID-19疾病血液学参数评估及其与疾病预后的相关性
Int J Hematol Oncol Stem Cell Res. 2023 Apr 1;17(2):89-99. doi: 10.18502/ijhoscr.v17i2.12645.
10
The promising approach of MSCs therapy for COVID-19 treatment.间充质干细胞治疗 COVID-19 的有前景的方法。
Cell Tissue Bank. 2023 Sep;24(3):597-612. doi: 10.1007/s10561-022-10060-2. Epub 2022 Dec 16.

本文引用的文献

1
ISTH interim guidance on recognition and management of coagulopathy in COVID-19.国际血栓与止血学会（ISTH）关于新冠病毒病（COVID-19）凝血病识别与管理的临时指南。
J Thromb Haemost. 2020 May;18(5):1023-1026. doi: 10.1111/jth.14810. Epub 2020 Apr 27.
2
Blood and blood product use during COVID-19 infection.新型冠状病毒肺炎感染期间的血液及血液制品使用情况。
Am J Hematol. 2020 Jul;95(7):E158-E160. doi: 10.1002/ajh.25823. Epub 2020 Apr 22.
3
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.抗凝治疗与伴有凝血功能障碍的严重 2019 冠状病毒病患者的死亡率降低相关。
J Thromb Haemost. 2020 May;18(5):1094-1099. doi: 10.1111/jth.14817. Epub 2020 Apr 27.
4
Prominent changes in blood coagulation of patients with SARS-CoV-2 infection.SARS-CoV-2 感染患者凝血功能的显著变化。
Clin Chem Lab Med. 2020 Jun 25;58(7):1116-1120. doi: 10.1515/cclm-2020-0188.
5
Hematologic parameters in patients with COVID-19 infection.新型冠状病毒肺炎（COVID-19）感染患者的血液学参数
Am J Hematol. 2020 Jun;95(6):E131-E134. doi: 10.1002/ajh.25774. Epub 2020 Mar 19.
6
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.异常的凝血参数与新型冠状病毒肺炎患者的预后不良有关。
J Thromb Haemost. 2020 Apr;18(4):844-847. doi: 10.1111/jth.14768. Epub 2020 Mar 13.